Fact CheckerSign in

NCT06933576Completed

Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel

Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel: A Multicenter Pilot Study on the First French Experiences.

Source: ClinicalTrials.gov · Last updated 18 Apr 2025

Brief summary (registry, in English)

Background and aims Digital single-operator cholangioscopy (DSOC) enhances biliary stricture diagnosis, but the collection of quality samples can be difficult due to the small diameter of the working channel. A new DSOC (EyeMAXTM 11Fr, Micro-Tech Endoscopy, Nanjing, China) with a 2.0 mm working channel, accommodating pediatric forceps (1.6 mm), has been introduced in France. This study reports on the initial French experience. Methods A retrospective multicenter observational study on DSOC was conducted across five endoscopy units within the CREGG (French Society of Private Hepato-Gastroenterology). Satisfaction and procedural evaluations were recorded using a visual analog scale (VAS) and compared with the SpyglassTM DS II DSOC (Boston Scientific).

Status (registry)
Completed
Study type
Observational
Enrollment
28 (actual)
First submitted
10 Apr 2025
Start date
1 Feb 2024
Primary completion date
30 Jan 2025
Lead sponsor
Clinique Paris-Bercy
NCT number
NCT06933576

What you commit to

  • Study type: Observational
  • Participants enrolled: 28
  • From 1 Feb 2024 to the primary completion date, 30 Jan 2025
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • non-accessibility to the bile duct due to a history of Billroth II or Roux-en-Y reconstruction,

Lab values

  • coagulation disorders (such as partial thromboplastin time \> 42 seconds, prothrombin time \[Quick value\] \< 50%, or platelet count \< 50,000/mm³), or treatment with clopidogrel.

Other

  • patients with significant tissue mass that could easily be punctured by EUS-FNB were not included.

Who the study is looking for

  • all consecutive patients who were referred to one of the participating expert tertiary endoscopy units for an ERCP for a bile duct stenosis

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clinique Paris Bercy
Coordinator of this site? Confirm its status
Charenton-le-PontFranceUnknown status
Louis Pasteur Clinic
Coordinator of this site? Confirm its status
Essey-lès-NancyFranceUnknown status
Jean Mermoz Private Hospital
Coordinator of this site? Confirm its status
LyonFranceUnknown status
Jules Verne Clinic
Coordinator of this site? Confirm its status
NantesFranceUnknown status
Arnaud Tzang Institut
Coordinator of this site? Confirm its status
Saint-Laurent-du-VarFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.